Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS)

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Schuster, Jens ^a   Karlsson, Teresia ^a   Karlström, Per Olof ^a,b   Poromaa, Inger S ^a   Dahl, Niklas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PGRMC1 PROTEIN, HUMAN; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BLOOD CELL; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PREMATURE OVARIAN FAILURE; PROTEIN EXPRESSION; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; METABOLISM; MONONUCLEAR CELL; PATHOLOGY;

ADULT; BLOOD CELLS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MENSTRUAL CYCLE; OVARIAN FAILURE, PREMATURE; POLYCYSTIC OVARY SYNDROME; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 77953254168     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-58     Document Type: Article

References (20)

1. Peluso JJ. Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary. Semin Reprod Med 2007, 25:198-207. 10.1055/s-2007-973432, 17447209.
2. Losel RM, Besong D, Peluso JJ, Wehling M. Progesterone receptor membrane component 1--many tasks for a versatile protein. Steroids 2008, 73:929-934. 10.1016/j.steroids.2007.12.017, 18249431.
3. Peluso JJ, Romak J, Liu X. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 2008, 149:534-543. 10.1210/en.2007-1050, 2219306, 17991724.
4. Gerdes D, Wehling M, Leube B, Falkenstein E. Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem 1998, 379:907-911. 10.1515/bchm.1998.379.7.907, 9705155.
5. Mansouri MR, Schuster J, Badhai J, Stattin L, Losel R, Wehling M, Carlsson B, Hovatta O, Karlstrom PO, Golovleva I, Toniolo D, Bione S, Peluso J, Dahl N. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet 2008, 17:3776-3783. 10.1093/hmg/ddn274, 2722898, 18782852.
6. Cahill MA. Progesterone receptor membrane component 1: an integrative review. J Steroid Biochem Mol Biol 2007, 105:16-36. 10.1016/j.jsbmb.2007.02.002, 17583495.
7. Engmann L, Losel R, Wehling M, Peluso JJ. Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. J Clin Endocrinol Metab 2006, 91:4962-4968. 10.1210/jc.2006-1128, 16984987.
8. Peluso JJ, Pappalardo A, Losel R, Wehling M. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. Endocrinology 2006, 147:3133-3140. 10.1210/en.2006-0114, 16513825.
9. Rohe HJ, Ahmed IS, Twist KE, Craven RJ. PGRMC1 (progesterone receptor membrane component 1): A targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther 2009, 121:14-19. 10.1016/j.pharmthera.2008.09.006, 2659782, 18992768.
10. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 2007, 5:143-149. 10.1016/j.cmet.2006.12.009, 17276356.
11. Zhang L, Kanda Y, Roberts DJ, Ecker JL, Losel R, Wehling M, Peluso JJ, Pru JK. Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human. Mol Cell Endocrinol 2008, 287:81-89. 10.1016/j.mce.2008.02.012, 18440126.
12. T.R.E.A.-s.P.c.-workshop Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19:41-47. 10.1093/humrep/deh098, 14688154, T.R.E.A.-s.P.c.-workshop.
13. Peluso JJ, Liu X, Saunders MM, Claffey KP, Phoenix K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J Clin Endocrinol Metab 2008, 93:1592-1599. 10.1210/jc.2007-2771, 18319313.
14. Peluso JJ, Liu X, Gawkowska A, Johnston-Macananny E. Progesterone Activates a Progesterone Receptor Membrane Component 1-dependent Mechanism That Promotes Human Granulosa/luteal Cell Survival But Not Progesterone Secretion. J Clin Endocrinol Metab 2009,
15. Nilsson EE, Stanfield J, Skinner MK. Interactions between progesterone and tumor necrosis factor-alpha in the regulation of primordial follicle assembly. Reproduction 2006, 132:877-886. 10.1530/REP-06-0045, 17127748.
16. Krebs CJ, Jarvis ED, Chan J, Lydon JP, Ogawa S, Pfaff DW. A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors. Proc Natl Acad Sci USA 2000, 97:12816-12821. 10.1073/pnas.97.23.12816, 18847, 11070092.
17. Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res 2008, 10:R85. 10.1186/bcr2155, 2614521, 18922159.
18. Roell A, Schueller P, Schultz A, Losel R, Wehling M, Christ M, Feuring M. Effect of oral contraceptives and ovarian cycle on platelet function. Platelets 2007, 18:165-170. 10.1080/09537100600936224, 17365866.
19. Goldstein J, Cushman M, Badger GJ, Johnson JV. Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. Fertil Steril 2007, 87:1267-1270. 10.1016/j.fertnstert.2006.11.040, 17336967.
20. Medina RA, Aranda E, Verdugo C, Kato S, Owen GI. The action of ovarian hormones in cardiovascular disease. Biol Res 2003, 36:325-341. 10.4067/S0716-97602003000300005, 14631866.